Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Senseonics Holdings ( (SENS) ).
On October 16, 2025, Senseonics Holdings, Inc. announced a one-for-twenty reverse stock split of its common stock, effective October 17, 2025. This adjustment will proportionately decrease the number of authorized shares and affect stock options, restricted stock units, and warrants, with trading on a split-adjusted basis beginning October 20, 2025, under the ticker symbol ‘SENS’.
The most recent analyst rating on (SENS) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Senseonics Holdings stock, see the SENS Stock Forecast page.
Spark’s Take on SENS Stock
According to Spark, TipRanks’ AI Analyst, SENS is a Neutral.
Senseonics Holdings’ overall stock score is primarily impacted by its financial performance, which remains a significant concern due to ongoing losses and high leverage. The earnings call provided a positive outlook with strong growth in new patient starts and revenue, but financial challenges persist. Technical analysis and valuation also present mixed signals, contributing to a moderate overall score.
To see Spark’s full report on SENS stock, click here.
More about Senseonics Holdings
Senseonics Holdings, Inc. operates in the medical technology industry, primarily focusing on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes.
Average Trading Volume: 7,282,901
Technical Sentiment Signal: Sell
Current Market Cap: $360.9M
See more data about SENS stock on TipRanks’ Stock Analysis page.